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Pseudohyperkalemia occurs occasionally in patients with extreme leukocytosis. Increased white blood cell fragility coupled with
mechanical stress is felt to be causal. Serum and plasma potassium levels have been both associated with pseudohyperkalemia.
Whole blood potassium determination will usually verify the correct diagnosis. It is important to diagnose this condition early
so that patients are not inappropriately treated. Two patients with chronic lymphocytic leukemia and extreme leukocytosis are
presented, one with pseudohyperkalemia and one with probable pseudohyperkalemia, and diagnostic considerations are discussed
1. Pseudohyperkalemia
Artifactual hyperkalemia or pseudohyperkalemia is most
commonlyseensecondarytoredcellhemolysis.Itisalsoseen
in patients with thrombocytosis and in the rare patient with
familial pseudohyperkalemia [1]. Not well appreciated is its
occasional occurrence in patients with extremely elevated
white blood cell counts, particularly in patients with chronic
lymphocytic leukemia (CLL). Here, two patients with CLL
and hyperkalemia are presented, and diagnostic issues are
discussed.
2.CaseReports
Case 1. The patient is a 51-year-old male who recently
was diagnosed with CLL and had not yet received any
chemotherapy. He was admitted with fatigue. He was on no
medications. His initial lab showed a plasma potassium of
6.8meq/L (repeated at 6.6meq/L), creatinine of 1.1mg/dL,
hemoglobin of 7.3g/dL, platelet count of 147K/UL, and
WBC of 273.9K/UL. No conduction abnormalities were
seen on EKG. He was treated in the emergency room for
his presumed hyperkalemia with calcium gluconate, sodium
bicarbonate, albuterol aerosol, glucose and insulin, and
kayexalate. Over the next two days his potassium generally
remained in the low 6’s, and nephrology was consulted. A
tentative diagnosis of pseudohyperkalemia was made, and
whole blood potassium was ordered using the blood gas
machine. The result was 2.7meq/L, conﬁrming the diagnosis
of pseudohyperkalemia. The next, day plasma potassium
was elevated at 9.0meq/L, but whole blood potassium was
3.6meq/L.
Case 2. The patient is a 90-year-old female with an eight-
year history of chronic lymphocytic leukemia. She had
recently refused further chemotherapy and had been on
hospice care. She also had a history of diabetes mellitus,
hypertension, chronic obstructive pulmonary disease, and
blindness. She had been on potassium chloride, furosemide,
and an angiotensin-converting enzyme inhibitor at home.
She was admitted to Tampa General Hospital for evaluation
of a fractured hip. She was virtually unresponsive. Plasma
potassium values over the initial 24 hours of her admission
ranged from 7.8meq/L to 10.2meq/L (Beckman Unicel
DxC800 using an ion selective electrode). Her creatinine
level ranged from 1.9mg/dL to 2.3mg/dL. Urinalysis showed
300mg% protein. Her white blood cell count was 986K/UL.
Her hemoglobin was 6.6g/dL and her platelet count was
79K/UL. She was initially given intravenous calcium and
placed on telemetry, but received no other treatment for
hyperkalemia.HerEKGshowedonlyaleftanteriorfascicular
block. A whole blood potassium level utilizing the blood
gas machine (Nova Biomedical Critical Care Express) was
10.6meq/L. At that point, her family decided to reconsult2 International Journal of Nephrology
hospice, and no further studies were performed. She
experienced no cardiac events during the six days of her
hospitalization.
3. Discussion
The cause of pseudohyperkalemia associated with extreme
leukocytosis is presumably cell lysis with release of intra-
cellular potassium. The etiology of this cell lysis can be
multifactorial. It was originally felt to be secondary to
clotting, but recent reports suggest mechanical issues may
also play a major part. The use of vacuum tubes [2],
pneumatic tube transportation [3–5], prolonged incubation,
and tourniquet use [6] have all been implicated as causing
cell lysis and pseudohyperkalemia. Recentrifugation after
storage in gel separator tubes has also been reported to cause
pseudohyperkalemia, and the degree of hyperkalemia was
noted to increase as storage times increased [7]. Increased
fragility of leukemic white cells is thought to contribute to
their tendency to lyse and liberate potassium. Depletion of
metabolites may contribute to the hyperkalemia associated
with prolonged storage [8].
The diagnosis of pseudohyperkalemia can be made in
a variety of ways. Comparison of serum and plasma can
be made, with the typical expectation being that the serum
potassium will be higher than the plasma potassium [9],
but observed results have been conﬂicting. Dimeski and
Bird [10] reported a patient with CLL in whom plasma
potassium was higher than serum potassium and suggested
that a likely reason was that the clotting process locks
the WBCs in the clot, eliminating cell movement during
mechanical stress processes and minimizing lysis. Guiheneuf
et al. [5] found that the eﬀect of pneumatic tube transport
on potassium was almost completely eliminated when serum
rather than plasma was used. Hembling et al. [11]r e p o r t e da
patient with CLL and an extraordinarily high WBC in whom
hyperkalemiawasobserved onlyin plasmaandnot in serum.
They speculated that there was an underlying abnormality
in the lymphocytes of their patient that conferred sensitivity
to lithium heparin anticoagulant. Abraham et al. [12]
also reported a leukemic patient with what they called
“reverse pseudohyperkalemia,” that is, pseudohyperkalemia
in plasma but not serum or whole blood. On the other
hand, Lee et al. [13] reported 4 patients with CLL in whom
hyperkalemia was noted in serum, but not in plasma or on
whole blood analysis using a blood gas analyzer. Sevastos
et al. [14], in a study of 435 patients with either thrombocy-
tosis, erythrocytoses, leukocytosis, or mixed-type disorders,
observed an elevated index Dk (serum potassium minus
plasma potassium) in patients with platelet, erythrocyte, or
with a mixed disorders but did not observe this diﬀerence in
a small subgroup of 20 patients with either CLL or AML. At
the M.D. Anderson Cancer Center plasma was found to be
the specimen of choice for potassium level determinations.
In a study of 37 paired samples, serum potassium values
were signiﬁcantly greater than those obtained from plasma
in average, and they found a signiﬁcant relationship between
serum potassium and platelet count, but not between plasma
potassium and platelet count [15].
Recently, the measurement of potassium on arterial
blood gas specimens has been reported to be a reliable
method of diagnosis. This may be due to the way the
blood is drawn and the rapid analysis of the specimen [16].
Smalley et al. [17] also observed the superiority of whole
blood samples in the diagnoses of pseudohyperkalemia and,
interestingly, noted no eﬀect of pneumatic tube transport
on the whole blood sample in contradistinction to the
hyperkalemia noted when their patient’s serum was tubed.
Our patients’ presentations and courses highlight the
issues involved in the diagnosis of pseudohyperkalemia
in a patient with a greatly elevated WBC. Patient no. 1’s
elevated potassium was initially not recognized as spurious
in spite of a normal EKG and lack of any clinical reason for
his hyperkalemia and he was thus brieﬂy inappropriately
treated. Patient no. 2’s clinical course is interesting in that
her whole blood potassium was also markedly elevated.
She had a dramatically elevated WBC, and the whole
blood sample was sent to the lab via the pneumatic tube
system. Unfortunately, because of her change in care status,
no conﬁrmatory tests were performed, but it is highly
improbable, although not impossible, that her extreme
hyperkalemia was real, as she had no typical EKG signs
of hyperkalemia and had no cardiac complications over
her hospital stay in spite of receiving no therapy for
hyperkalemia. The probability of EKG changes increases
with increasing potassium levels [18], and serum potassium
levels higher than 8mmol/L are almost invariably associated
with EKG changes [19]. On the other hand, there have been
reports of patients with extremely elevated potassium levels
and unremarkable EKG ﬁndings, generally in patients with
renal failure [19, 20]. It is speculated that her WBC of almost
one million made her blood sample much more susceptible
to stresses of the blood draw and the pneumatic tube system.
In the presence of substantial leukocytosis, clinicians
need to be alert to the possibility of a spurious potassium
result. The suggestion in this situation is to immediately
obtain a potassium level by blood gas analysis, as this
is an extremely quick and reliable test. If the WBC is
extraordinarily elevated, then steps to minimize trauma to
the blood sample should be implemented even if whole
blood is used. It has also been suggested that the hospital
information system ﬂag potassium results in patients with
WBC counts >100 × 103 noting the relationship between
extreme leukocytosis and pseudohyperkalemia [13].
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